Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy
2018-06
发表期刊MOLECULES (IF:4.2[JCR-2023],4.6[5-Year])
ISSN1420-3049
卷号23期号:6
发表状态已发表
DOI10.3390/molecules23061326
摘要Abnormally O-glycosylated MUC1 tandem repeat glycopeptide epitopes expressed by multiple types of cancer have long been attractive targets for therapy in the race against genetic mutations of tumor cells. Glycopeptide signature-guided therapy might be a more promising avenue than mutation signature-guided therapy. Three O-glycosylated peptide motifs, PDTR, GSTA, and GVTS, exist in a tandem repeat HGVTSAPDTRPAPGSTAPPA, containing five O-glycosylation sites. The exact peptide and sugar residues involved in antibody binding are poorly defined. Co-crystal structures of glycopeptides and respective monoclonal antibodies are very few. Here we review 3 groups of monoclonal antibodies: antibodies which only bind to peptide portion, antibodies which only bind to sugar portion, and antibodies which bind to both peptide and sugar portions. The antigenicity of peptide and sugar portions of glyco-MUC1 tandem repeat were analyzed according to available biochemical and structural data, especially the GSTA and GVTS motifs independent from the most studied PDTR. Tn is focused as a peptide-modifying residue in vaccine design, to induce glycopeptide-binding antibodies with cross reactivity to Tn-related tumor glycans, but not glycans of healthy cells. The unique requirement for the designs of antibody in antibody-drug conjugate, bi-specific antibodies, and chimeric antigen receptors are also discussed.
关键词MUC1 tandem repeat antibodies glycopeptide co-crystal
收录类别SCI ; SCIE
语种英语
资助项目National Key Research and Development Plan[2017YFA0505901]
WOS研究方向Biochemistry & Molecular Biology ; Chemistry
WOS类目Biochemistry & Molecular Biology ; Chemistry, Multidisciplinary
WOS记录号WOS:000435875400088
出版者MDPI
WOS关键词MHC CLASS-I ; ANTI-MUC1 MONOCLONAL-ANTIBODY ; SYNTHETIC ANTITUMOR VACCINES ; HUMAN-IMMUNOGLOBULIN HEAVY ; TUMOR-ASSOCIATED MUC1 ; SIALYL-TN-ANTIGENS ; BREAST-CARCINOMA ; O-GLYCOSYLATION ; CHEMOENZYMATIC SYNTHESIS ; CARBOHYDRATE STRUCTURES
原始文献类型Review
引用统计
正在获取...
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/27411
专题免疫化学研究所_特聘教授组_抗体结构学实验室
iHuman研究所_PI研究组_程建军组
通讯作者Zhou, Dapeng; Xu, Lan
作者单位
1.Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
2.ShanghaiTech Univ, Lab Antibody Struct, Shanghai Inst Adv Immunochem Studies, Shanghai 201203, Peoples R China
3.ShanghaiTech Univ, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, Chinese Acad Sci, Shanghai 201203, Peoples R China
4.ShanghaiTech Univ, IHuman Inst, Shanghai 201203, Peoples R China
5.German Red Cross Blood Donat Serv North East, Inst Transfus Med Dresden, D-01307 Dresden, Germany
6.Carl Gustav Carus Tech Univ, Fac Med, D-01307 Dresden, Germany
通讯作者单位免疫化学研究所
推荐引用方式
GB/T 7714
Zhou, Dapeng,Xu, Lan,Huang, Wei,et al. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy[J]. MOLECULES,2018,23(6).
APA Zhou, Dapeng,Xu, Lan,Huang, Wei,&Tonn, Torsten.(2018).Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.MOLECULES,23(6).
MLA Zhou, Dapeng,et al."Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy".MOLECULES 23.6(2018).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Zhou, Dapeng]的文章
[Xu, Lan]的文章
[Huang, Wei]的文章
百度学术
百度学术中相似的文章
[Zhou, Dapeng]的文章
[Xu, Lan]的文章
[Huang, Wei]的文章
必应学术
必应学术中相似的文章
[Zhou, Dapeng]的文章
[Xu, Lan]的文章
[Huang, Wei]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 27411.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。